Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

S.-H. Liu, K.-W. Hsu, Y.-L. Lai, Y.-F. Lin, Fang-Hsin Chen, P.-H. Peng, L.-J. Lin, H.-H. Wu, C.-Y. Li, S.-C. Wang, M.-Z. Wu, Y.-P. Sher, W.-C. Cheng

研究成果: 期刊稿件文章同行評審

12 引文 斯高帕斯(Scopus)

摘要

Lung adenocarcinoma (LUAD), the most common histological type of non-small cell lung cancer, is one of the most malignant and deadly diseases. Current treatments for advanced LUAD patients are far from ideal and require further improvements. Here, we utilized a systematic integrative analysis of LUAD microRNA sequencing (miRNA-seq) and RNA-seq data from The Cancer Genome Atlas (TCGA) to identify clinically relevant tumor suppressor miRNAs. Three miRNA candidates (miR-195-5p, miR-101-3p, and miR-338-5p) were identified based on their differential expressions, survival significance levels, correlations with targets, and an additive effect on survival among them. We further evaluated mimics of the three miRNAs to determine their therapeutic potential in inhibiting cancer progression. The results showed not only that each of the miRNA mimics alone but also the three miRNA mimics in combination were efficient at inhibiting tumor growth and progression with equal final concentrations, meaning that the three miRNA mimics in combination were more effective than the single miRNA mimics. Moreover, the combined miRNA mimics provided significant therapeutic effects in terms of reduced tumor volume and metastasis nodules in lung tumor animal models. Hence, our findings show the potential of using the three miRNAs in combination to treat LUAD patients with poor survival outcomes.
原文美式英語
頁(從 - 到)1-10
期刊Molecular Therapy - Nucleic Acids
25
DOIs
出版狀態已出版 - 2021

指紋

深入研究「Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma」主題。共同形成了獨特的指紋。

引用此